Iressa Shrinks Some Lung Tumors, Reduces Symptoms In Phase II Trial
New Biologic Modalities Show Promise In Treatment Of Lymphomas, Research Finds
Docetaxel As Adjuvant Therapy Shows Benefit Over Standard
QOL Of Anemic Patients Improved With Darbepoetin
UC Davis Study Finds Patients Need Practical Information
Clinical Trials Approved By NCI CTEP During May
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era
- Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Kim Rathmell named OSUCCC director, Pollock becomes director emeritus in planned leadership transition
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ









